Last reviewed · How we verify
TD-5108
At a glance
| Generic name | TD-5108 |
|---|---|
| Sponsor | Alfasigma S.p.A. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). (PHASE2)
- Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial) (PHASE2)
- Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects (PHASE1)
- The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study (PHASE2)
- Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |